Tag: mechanochemical ablation

RCT: Technical success rates of mechanochemical ablation are inferior to thermal...

Three-year results of a randomised controlled trial reveal that, while mechanochemical ablation (MOCA) is a “feasible treatment option” in an outpatient setting, its technical...
Venous News for specialists

Mechanochemical ablation presents advantages over EVLA in randomised trial of varicose...

Mechanochemical ablation (MOCA) is a superior option to endovenous laser ablation (EVLA) for the treatment of primary varicose veins, according to the findings of...

Four-year mechanochemical ablation data shared at EVF

At the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal), Mattia Mirandola (Peschiera del Garda, Italy) presented his four-year experience of using ClariVein...

MOCA effective for greater saphenous vein insufficiency out to three years

A Dutch study of greater saphenous vein insufficiency patients has found that mechanochemical ablation (MOCA; ClariVein, Vascular Insights) is an effective and safe treatment...